Stemsation International (STSN) Stock Price, News & Analysis
Company Description
Stemsation International (OTC Link: STSN) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $5.6M.
STSN has gained 115.2% over the past year. Shares last traded at $0.0170.
This page collects what Stock Titan holds for STSN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Stemsation International (STSN) stock last traded at $0.0170, up 13.33% from the previous close. Over the past 12 months, the stock has gained 115.2%. At a market capitalization of $5.6M, STSN is classified as a micro-cap stock with approximately 620.5M shares outstanding.
Latest News
Stemsation International has 8 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition. View all STSN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Stemsation International (STSN) currently stands at 95.8 thousand shares, up 41.1% from the previous reporting period, representing 0.0% of the shares outstanding. Over the past 12 months, short interest has increased by 197.5%.
Days to Cover History
Days to cover for Stemsation International (STSN) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
STSN Company Profile & Sector Positioning
Stemsation International (STSN) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing STSN often look at related companies in the same sector, including Cv Sciences (CVSI), Marijuana Inc. (MAJI), Cannabis Bioscience International Holdings Inc (CBIH), StateHouse Holdings Inc (STHZF), and Crescita Therape (CRRTF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate STSN's relative position within its industry.